Cell proliferation in 3,800 node-negative breast cancers: Consistency over time of biological and clinical information provided by 3H-thymidine labelling index

International Journal of Cancer

Volumn 74, Issue 1, 1997, Pages 122-127

  Silvestrini, Rosella ^a   Daidone, Maria Grazia ^a   Luisi, Antonella ^a   Mastore, Marinella ^a   Leutner, Monica ^a   Salvadori, Bruno ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

THYMIDINE;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; BREAST NEOPLASMS; CELL DIVISION; CONFIDENCE INTERVALS; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MITOTIC INDEX; NEOPLASM METASTASIS; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; PREMENOPAUSE; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RECURRENCE; SURVIVAL RATE; THYMIDINE; TRITIUM; TUMOR MARKERS, BIOLOGICAL;

EID: 0030905685     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970220)74:1<122::AID-IJC20>3.0.CO;2-G     Document Type: Article

References (30)

1. CLARK, G.M., Do we really need prognostic factors for breast cancer? Breast Cancer Res. Treat., 30, 117-126 (1994).
2. CLARK, G.M., HILSENBECK, G., RAVDIN, P.M., DE LAURENTIS, M. and OSBORNE, K., Prognostic factors: rationale and methods of analysis and integration. Breast Cancer Res. Treat., 32, 105-112 (1994).
3. CLARK, G.M., MATHIEU, M.C., OWENS, M.A., DRESSLER, L.G., EUDEY, L., TORMEY, D.C., OSBORNE, C.K., GILCHRIST, K.W., MANSOUR, E.G., ABELOFF, M.D. and MCGUIRE, W.L., Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients. J. clin. Oncol., 10, 428-432 (1992).
4. CLARK, G.M., WENGER, C.R., BEARDSLEE, S., OWENS, M.A., POUNDS, G., OLDAKER, T., VENDELY, P., PANDIAN, M.K., HARRINGTON, A. and MCGUIRE, W.L., How to integrate steroid hormone receptor, flow cytometry, and other prognostic information in regards to primary breast cancer. Cancer, 71, 2157-2162 (1993).
5. COBLEIGH, M.A., SIDDIQUI, S., OLESKE, D.M. and ROSEMAN, D.L., Study of tumor S-phase in postmenopausal women diagnosed with breast cancer while using hormone replacement therapy vs. those never having used hormone replacement therapy. Proc. Amer. Ass. Cancer Res., 37, 203 (1996).
6. COOKE, T.G., STANTON, P.D., WINSTANLEY, J., MURRAY, G.D., CROTON, R., HOLT, S. and GEORGE, W.D., Long-term prognostic significance of thymidine labelling index in primary breast cancer. Europ. J. Cancer, 28, 424-426 (1992).
7. GASPARINI, G., POZZA, F. and HARRIS, A.L., Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients. J. nat. Cancer Inst., 85, 1206-1219(1993).
8. GLICK, J.H., GELBER, R.D., GOLDHIRSCH, A. and SENN, H.J., Meeting highlights: adjuvant therapy for primary breast cancer. J. nat. Cancer Inst., 84, 1479-1485 (1992).
9. HERY, M., GIANNI, J., LALANNE, C.M., NAMER, M. and COURDI, A., The DNA labeling index: a prognostic factor in node-negative breast cancer. Breast Cancer Res. Treat., 9, 207-211 (1987).
10. HILSENBECK, S.G., CLARK, G.M. and MCGUIRE, W.L., Why do so many prognostic factors fail to pan out? Breast Cancer Res. Treat., 22, 197-206 (1992).
11. KALBFLEISH, J.D. and PRENTICE, R.L., The statistical analysis of failure time data. J. Wiley, New York (1980).
12. KUTE, T.E., SHAO, Z.M., SUGG, K., LONG, R.T., RUSSELL, G.B. and CASE, L.D., Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays. Cancer Res., 52, 5198-5203 (1992).
13. MEYER, J.S. and PROVINCE, M., Proliferative index of breast carcinoma by thymidine labeling: prognostic power independent of stage, estrogen and progesterone receptors. Breast Cancer Res. Treat., 12, 191-204 (1988).
14. NIH CONSENSUS CONFERENCE. Treatment of early-stage breast cancer. J. amer. Med. Ass., 265, 391-395 (1991).
15. O'REILLY, S.M., CAMPLEJOHN, R.S., BARNES, D.M., MILLIS, R.R., RUBENS, R.D. and RICHARD, M.A., Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry. J. clin. Oncol., 8, 2040-2045 (1990).
16. RONCHI, E., GRANATA, G., BRIVIO, M., CORADINI, D., MIODINI, P. and DI FRONZO, G., A double-labeling assay for simultaneous estimation and characterization of estrogen and progesterone receptors using radioiodinated estradiol and tritiated Org 2058. Tumori, 72, 251-257 (1986).
17. 3H-dT labeling index in breast cancer. Cell Prolif., 24, 437-445 (1991).
18. SILVESTRINI, R., Cell kinetics: prognostic and therapeutic implications in human tumours. Cell Prolif., 27, 579-596 (1994a).
19. SILVESTRINI, R., Quality control for the evaluation of the S-phase fraction by flow-cytometry: a multicentric study. The SICCAB Group for Quality Control of Cell Kinetic Determination. Cytometry, 18, 11-16 (1994b).
20. SILVESTRINI, R., BENINI, E., DAIDONE, M.G., VENERONI, S., BORACCHI, P., CAPPELLETTI, V., DI FRONZO, G. and VERONESI, U., p53 as an independent prognostic marker in node-negative breast cancers. J. nat. Cancer Inst., 85, 965-970 (1993a).
21. SILVESTRINI, R., DAIDONE, M.G., DEL BINO, G., MASTORE, M., DI FRONZO, G. and BORACCHI, P., Prognostic significance of proliferative activity and ploidy in node-negative breast cancers. Ann. Oncol., 4, 213-219 (1993b).
22. SILVESTRINI, R., DAIDONE, M.G., DI FRONZO, G., MORABITO, A., VALAGUSSA, P. and BONADONNA, G., Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer Breast Cancer Res. Treat., 7, 161-169 (1986).
23. SILVESTRINI, R., DAIDONE, M.G., LUISI, A., BORACCHI, P., MEZZETTI, M., DI FRONZO, G., ANDREOLA, S. and VERONESI, U., Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer. J. clin. Oncol., 13, 697-704 (1995).
24. SILVESTRINI, R., DAIDONE, M.G., MASTORE, M., DI FRONZO, G., CORADINI, D., BORACCHI, P., SQUICCIARINI, P., SALVADORI, B. and VERONESI, U., Cell kinetics as a predictive factor in node-positive breast cancer treated with adjuvant hormone therapy. J. clin. Oncol., 11, 1150-1155 (1993c).
25. 3H-thymidine-labeling index as a prognostic indicator in node-positive breast cancer. J. clin. Oncol., 8, 1321-1326 (1990).
26. SILVESTRINI, R., DAIDONE, M.G., VALAGUSSA, P., SALVADORI, B., ROVINI, D. and BONADONNA, G., Cell kinetics and prognosis in locally advanced breast cancer. Cancer Treat. Rep., 71, 375-379 (1987).
27. STANTON, P.D., OAKES, S.J., MURRAY, G.D., WINSTANLEY, J., COOKE, T.G. and GEORGE, W.D., Lack of prognostic significance of ploidy and S-phase fraction in human breast cancer. Brit. J. Cancer. 66, 925-929 (1992).
28. TUBIANA, M., PEJOVIC, M.H., KOSCIELNY, S., CHAVAUDRA, N. and MALAISE, E., Growth rate, kinetics of tumor cell proliferation and long-term outcome in human breast cancer. Int. J. Cancer, 44, 17-22 (1989).
29. 3H-thymidine labeling index, hormone receptors, and ploidy in breast cancers from elderly patients. Breast Cancer Res. Treat., 20, 19-24 (1991).
30. VERONESI, U. and 14 OTHERS, Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N. Engl. J. Med., 305, 6-11 (1981).